| 08:30 | Registration and refreshments |
|
| 09:15 | Chairman’s opening remarks Chris Smith, Editor and Conference Manager
European Plastics News |
|
| 09:30 | Planning for the future: market growth, change, opportunities and threats -
Discussing the impact of recent legislative changes -
Assessing commercial phthalate alternatives -
Recommendations to the industry to maintain and grow market share Dr David Cadogan, Director
European Council for Plasticisers and Intermediates (ECPI) |
|
| 10:15 | Question and answer session |
|
| 10:30 | |
|
| 11:00 | Extended REACH session -
Taking advantage of the transitional period by pre-registering -
Looking at how to submit dossiers for plasticisers – what is required and what is the process? -
Considering the long-term implications, given what we now know of REACH -
REACH Confidential – Q&A surgery (questions submitted in advance) Giovanni Indirli, Associate
Mayer Brown |
|
| 11:45 | Navigating the regulatory terrain and achieving FDA approval – a case study and exploration of a phthalate alternative
-
Discussing the approval process for Mesamoll II – requirements and challenges -
Examining the use of Mesamoll II in products that come into contact with aqueous based foodstuffs and in toys -
Considering suitable applications: -
Polyurethane -
Acrylonitrile butadiene rubber -
PVC Dr. Elie Saad, BU Functional Chemicals, Polymer Additives
Lanxess Deutschland |
|
| 12:15 | Question and answer session |
|
| 12:30 | |
|
| 14:00 | Studies on human exposure to phthalates Prof. Dr. Jürgen Angerer, Head of Laboratory
Insitut für Arbeits-Sozial und Umweltmedizin |
|
| 14:30 | Plasticisers in flooring applications – examining needs and challenges -
Looking at the use of plasticisers in bulk applications -
Will the flooring industry move towards phthalate alternatives, and if so, how will this impact the market? Pete Thomas, Environmental Manager
Tarkett |
|
| 15:00 | Question and answer session |
|
| 15:15 | |
|
| 15:45 | Case study: plasticisers for human contact applications -
Looking at applications in toys -
Exploring toxicity and performance -
Do alternative plasticisers require reformulation – exploring possible effects on the finished product
Dr. Rainer Otter, Head Regulatory Toxicology Chemicals
BASF |
|
| 16:15 | Case study 2: plasticisers for human contact applications Dr Mark Holt, Global Business Development Manager
Eastman Chemical Company |
|
| 16:45 | Question and answer session |
|
| 17:00 | Chairman’s closing remarks and end of day one |
|
| 19:30 | Conference dinner for speakers and delegates
At La Manufacture, 12-20 Rue Notre Dame du Sommeil, Brussels 1000 |
| |
